Best case scenario is public plans for an uplist. Worst case is no follow up on publicy revealed plans with dilution. But they appear to be moving forward with their agenda so let’s hope Joe pushes his vision forward.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
